Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,489	8,029	4,461	3,908	3,497	2,721
Market Cap Growth	-20.62%	80.00%	14.13%	11.77%	28.52%	20.11%
Enterprise Value	6,144	8,510	5,080	4,148	3,763	3,110
Last Close Price	26.70	36.00	20.00	20.90	18.70	14.55
PE Ratio	47.02	74.78	200.14	-	-	-
PS Ratio	5.08	6.57	5.01	7.64	7.55	6.60
PB Ratio	2.62	4.49	2.67	3.59	3.13	2.24
P/TBV Ratio	3.17	6.10	3.92	3.63	3.17	2.28
P/FCF Ratio	23.60	47.32	-	-	-	-
P/OCF Ratio	20.42	40.76	-	343.32	-	-
EV/Sales Ratio	4.81	6.96	5.71	8.10	8.12	7.55
EV/EBITDA Ratio	19.01	31.21	36.55	333.67	-	-
EV/EBIT Ratio	32.38	53.89	208.88	-	-	-
EV/FCF Ratio	22.34	50.16	-	-	-	-
Debt / Equity Ratio	0.08	0.31	0.43	0.47	0.37	0.27
Debt / EBITDA Ratio	0.62	1.87	4.52	20.74	-	-
Debt / FCF Ratio	0.73	3.22	-	-	-	-
Asset Turnover	-	0.48	0.40	0.28	0.26	0.25
Inventory Turnover	-	2.23	1.97	2.03	2.17	2.67
Quick Ratio	3.58	0.82	0.53	0.51	0.55	1.08
Current Ratio	5.33	1.50	1.11	1.21	1.05	1.73
Return on Equity (ROE)	-	6.21%	1.62%	-2.61%	-8.80%	-15.56%
Return on Assets (ROA)	-	3.88%	0.69%	-1.44%	-4.76%	-6.30%
Return on Invested Capital (ROIC)	6.33%	4.62%	1.25%	-2.90%	-9.78%	-12.61%
Return on Capital Employed (ROCE)	7.10%	7.80%	1.20%	-2.80%	-9.90%	-11.20%
Earnings Yield	1.97%	1.34%	0.50%	-0.74%	-2.94%	-6.30%
FCF Yield	4.24%	2.11%	-3.52%	-0.43%	-3.43%	-8.17%
Buyback Yield / Dilution	-1.06%	-	-19.27%	0.00%	-10.40%	-8.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.